Recombinant CALCA, CALCB (Fremanezumab Biosimilar) anticorps

N° du produit ABIN7597700

Cet anticorps anti-CALCA, CALCB (Fremanezumab Biosimilar) est un anticorps Humanized Chimeric détectant CALCA, CALCB (Fremanezumab Biosimilar) dans . Adapté pour Humain.

Aperçu rapide pour Recombinant CALCA, CALCB (Fremanezumab Biosimilar) anticorps (ABIN7597700)

Antigène: CALCA, CALCB (Fremanezumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Chimeric

Conjugué: Cet anticorp CALCA, CALCB (Fremanezumab Biosimilar) est non-conjugé

Classe de qualité: Research Grade

Détail du produit anti-CALCA, CALCB (Fremanezumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Research Grade Fremanezumab Biosimilar Antibody

Specificité: CCP, PDN-21, CALCA, Calcitonin carboxyl-terminal peptide, Calcitonin, CALC1, Calcitonin gene-related peptide II, CALCB, Calcitonin gene-related peptide 2, Beta-CGRP, CALC2, CGRP-II, Beta-type CGRP

Purification: Protein A or G purified from cell culture supernatant.

Pureté: >95 % by SDS-PAGE.

Isotype: IgG2 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Date de péremption: 12 months

Détails sur CALCA, CALCB (Fremanezumab Biosimilar)

Antigène: CALCA, CALCB (Fremanezumab Biosimilar)

Autre désignation: Fremanezumab Biosimilar

Classe de substances: Biosimilar

Sujet: CCP, PDN-21, CALCA, Calcitonin carboxyl-terminal peptide, Calcitonin, CALC1, Calcitonin gene-related peptide II, CALCB, Calcitonin gene-related peptide 2, Beta-CGRP, CALC2, CGRP-II, Beta-type CGRP

UniProt: P01258, P10092

Numéro CAS: 1655501-53-3